Replimune Group, Inc. (REPL)
7.75
+0.82
(+11.83%)
USD |
NASDAQ |
Feb 06, 16:00
7.745
0.00 (0.00%)
After-Hours: 20:00
Replimune Group SG&A Expense (TTM) : 103.07M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| CorMedix, Inc. | 75.56M |
| Verastem, Inc. | 67.48M |
| Sarepta Therapeutics, Inc. | 527.29M |
| Anavex Life Sciences Corp. | 13.82M |
| Ocugen, Inc. | 27.76M |